Economics and capital · Exits liquidity
Iambic Therapeutics Files For Proposed Public Offering
Nvidia-backed AI biotech Iambic Therapeutics filed to go public and said its lead cancer drug could enter a registrational trial as early as next year.
Read the original at endpoints.newsOpens the publisher's site in a new tab